Cationic peptide exposure enhances pulsed-electric-field-mediated membrane disruption

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Kennedy, Stephen M ^a,b   Aiken, Erik J ^b   Beres, Kaytlyn A ^b   Hahn, Adam R ^b   Kamin, Samantha J ^b   Hagness, Susan C ^b   Booske, John H ^b   Murphy, William L ^b,c  

^a HARVARD UNIVERSITY   (United States)

^b University of Wisconsin Madison   (United States)

^c UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CATION; PEPTIDE DERIVATIVE; POLYARGININE; PROPIDIUM IODIDE; PEPTIDE;

ARTICLE; CELL MEMBRANE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROPORATION; EXPOSURE; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; INTERNALIZATION; LEUKEMIA CELL; MEMBRANE DAMAGE; PULSED ELECTRIC FIELD; CELL MEMBRANE PERMEABILITY; DRUG EFFECTS; ELECTRICITY; ENDOCYTOSIS; HL 60 CELL LINE; METABOLISM; STATIC ELECTRICITY;

CATIONS; CELL MEMBRANE; CELL MEMBRANE PERMEABILITY; ELECTRICITY; ENDOCYTOSIS; HL-60 CELLS; HUMANS; PEPTIDES; PROPIDIUM; STATIC ELECTRICITY;

EID: 84899993011     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0092528     Document Type: Article

References (65)

1. Adibor IG, Arakelyan VB, Chernomordik LV, Chizmadzhev YA, Pastushenko VF, et al. (1979) Electric breakdown of bilayer lipid membranes I: the main experimental facts and their qualitative discussion. Bioelectrochem Bioenerg 6: 37-52. (Pubitemid 9199834)
2. Chizmadzhev YA, Arakelyan VB, Pastushenko VF (1979) Electric breakdown of bilayer lipid membranes III: analysis of possible mechanisms of defect origination. Bioelectrochem Bioenerg 6: 63-70. (Pubitemid 9199836)
3. Arakelyan VB, Chizmadzhev YA, Pastushenko VF (1979) Electric breakdown of bilayer lipid membranes V: consideration of the kinetic stage in the case of the membrane containing an arbitrary number of defects. Bioelectrochem Bioenerg 6: 81-87. (Pubitemid 9199838)
4. Pastushenko VF, Chizmadzhev YA, Arakelyan VB (1979) Electric breakdown of bilayer lipid membranes II: Calculation of the membrane lifetime in the steady-state diffusion approximation. Bioelectrochem Bioenerg : 6 53-62. (Pubitemid 9199835)
5. Pastushenko VF, Chizmadzhev YA, Arakelyan VB (1979) Electric breakdown of bilayer lipid membranes IV: consideration of the kinetic stage in the case of the single-defect membrane Bioelectrochem Bioenerg 6: 71-79. (Pubitemid 9199837)
6. Pastushenko VF, Arakelyan VB, Chizmadzhev YA (1979) Electric breakdown of bilayer lipid membranes VI: a stochastic theory taking into account the processes of defect formation and death: membrane lifetime distribution function. Bioelectrochem Bioenerg 6: 89-95. (Pubitemid 9199839)
7. Pastushenko VF, Arakelyan VB, Chizmadzhev YA (1979) Electric breakdown of bilayer lipid membranes VII: a stochastic theory taking into account the processes of defect formation and death: statistical properties. Bioelectrochem Bioenerg 6: 97-104. (Pubitemid 9199840)
8. Neumann E, Sowers AE, Jordan CA, Eds. (1989) Electroporation and Electrofusion in Cell Biology. New York: Plenum.
9. Chang C, Chassy BM, Saunders JA, Sowers AW (1992) Guide to Electroporation and Electrofusion. San Diego: Academic Press.
10. Zimmerman U, Neil GA (1996) Electromanipulation of Cells. Boca Raton: CRC Press.
11. Weaver JC (2000) Electroporation of cells and tissues. IEEE Trans Plasma Sci 28: 24-33.
12. Dev SB, Rabussy DP, Wider G, Hoffman GA (2000) Medical applications of electroporation. IEEE Trans Plasma Sci 28: 206-233.
13. Andre F, Mir LM (2004) DNA electrotransfer: its principles and an updated review of its therapeutic applications. Gene Ther 11: S33-S42. (Pubitemid 39359445)
14. Nishi T, Yoshizato K, Yamashiro S, Takeshima H, Sato K, et al. (1996) High-efficiency in vivo gene transfer using intraaterial plasmid DNA injection following in vivo electroporation. Cancer Res 56: 1050-1055. (Pubitemid 26065399)
15. Gehl J (2003) Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Scand 177: 437-447.
16. Lin J, Chen R, Feng S, Li Y, Huang Z, et al. (2009) Rapid delivery of silver nanoparticles into living cells by electroporation for surface-enhanced Raman spectroscopy. Biosens Bioelectron 25: 388-394.
17. Schelly ZA (2007) Subnanometer size uncapped quantum dots via electroporation of synthetic vesicles. Colloids Surf B 56: 281-284.
18. Kennedy SM, Ji Z, Hedstrom JC, Booske JH, Hagness SC (2008) Quantification of electroporative uptake kinetics and electric field heterogeneity effects in cells. Biophys J 94: 5018-5027.
19. Müller KJ, Sukhorukov VL, Zimmermann U (2001) Reversible electropermeabilization of mammalian cells by high-intensity, ultra-short pulses of submicrosecond duration. J Membrane Biol 184: 161-170. (Pubitemid 33064357)
20. Rubinsky B (2007) Irreversible electroporation in medicine. Technol Cancer Res Treat 6: 255-259.
21. Esser AT, Smith KC, Gowrishankar TR, Weaver JC (2007) Towards solid tumor treatment by irreversible electroporation: Intrinsic redistribution of fields and currents in tissue. Technol Cancer Res Treat 6: 261-273. (Pubitemid 47340118)
22. Rubinsky B, Onik G, Mikus P (2007) Irreversible electroporation: a new ablation modality-clinical applications. Technol Cancer Res Treat 6: 37-48. (Pubitemid 46389347)
23. Al-Sakere B, André F, Bernat C, Connault E, Opolon P, et al. (2007) Tumor ablation with irreversible electroporation. PLoS ONE 2: e1135.
24. Maor E, Ivorra A, Rubinsky B (2009) Non thermal irreversible electroporation: novel technology for vascular smooth muscle cells ablation. PLoS ONE 4: e4757.
25. Binder H, Lindblom G (2003) Charge-dependent translocation of the Trojan peptide penetratin across lipid membranes. Biophys J 85: 982-995. (Pubitemid 36909662)
26. Wadia JS, Dowdy SF (2005) Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer Adv. Drug Deliv. Rev. 57 579-596. (Pubitemid 40255562)
27. Wender PA, Mitchell DJ, Pattabiramann K, Pelkey ET, Steinman L, et al. (2000) The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters. Proc Natl Acad Sci 97: 13003-13008.
28. Palm-Apergi C, Lorents A, Padari K, Pooga M, Hällbrink M (2009) The membrane repair response masks membrane disturbances caused by cell-penetrating peptide uptake. FASEB J 23: 214-223.
29. Miteva M, Anderson M, Karshkoff A, Otting G (1999) Molecular electroporation: a unifying concept for the description of membrane pore formation by antibacterial peptides, exemplified with NK-lysin. FEBS Lett 462: 155-158.
30. De Smedt SC, Demeester J, Hennik WE (2000) Cationic polymer based gene delivery systems. Pharm. Res. 17: 113-126. (Pubitemid 30158358)
31. Kunath K, von Harpe A, Fischer D, Petersen H, Bickel U et al. (2003) Low-molecular-weight polyethylenimine as a non-viral vector for DNA delivery: comparison of physicochemical properties, transfection efficiency and in vivo distribution with high-molecular-weight polyethylenimine. J. Contr. Rel. 89: 113-125. (Pubitemid 36412116)
32. Mislick KA, Baldeschwielerr JD (1996) Evidence for the role of proteoglycans in cation-mediated gene transfer. Proc. Natl. Acad. Sci. USA 93: 1249-12354.
33. Haensler J, Szoka FCJ (1993) Polyamidoamine cascade polymers mediate efficient transfection of cells in culture. Bioconjug.chem. 4: 372-279.
34. Pouton CW, Lucas P, Thomas BJ, Uduehi AN, Milroy DA, et al. (1998) Polycation-DNA complexes for gene delivery: a comparison of the biopharmaceutical properties of cationic polypeptides and cationic lipids. J.Contr. Rel. 53: 289-299. (Pubitemid 28218712)
35. Tang MX, Szoka FC (1997) The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes. Gene Therapy 4: 823-832. (Pubitemid 27380165)
36. Ivorra A, Villemejane J, Mir JM (2010) Electrical modeling of the influence of medium conductivity on electroporation. Phys. Chem. Chem. Phys. 12: 10055-1062.
37. Neumann E (1992) Membrane electroporation and direct gene transfer. Bioelectrochem. Bioenerg. 28: 247-267.
38. Puchihar G, Kotnik T, Kanduser M, Miklaveic D (2001) The influence of medium conductivity on electropermeabilization and survival of cells in vitro. Bioelectrochemistsry 54: 107-115. (Pubitemid 32990047)
39. Ferreira E, Potier E, Logeart-Avramoglou D, Salomskaite-Davalgiene S, Mir LM, et al. (2008) Optimization of a gene electrotransfer method for mesenchymal stem cell transfection. Gene Ther. 15: 537-544. (Pubitemid 351405094)
40. Pakhomova ON, Gregory BW, Khorokhorina VA, Bowman AM, Xiao S, et al. (2011) Electroporation-induced electrosensitization. PLoS ONE 6: e17100.
41. Pakhomov AG, Kolb JF, White JA, Joshi RP, Xiao S, et al. (2007) Long-lasting plasma membrane permeabilization in mammalian cells by nanosecond pulsed electric field nsPEF. Bioelectromagnetics. 28: 655-663. (Pubitemid 350190628)
42. Zhelev DV, Needham D (1993) Tension stabilized pores in giant vesicles: Determination of pore size and pore line tension. Biochim Biophys Acta 1147: 89-104. (Pubitemid 23104892)
43. Puc M, Kotnik T, Mir LM, Miklavcic D (2003) Quantitative model of small molecules uptake after in vitro cell electropermeabilization. Bioelectrochemistry 60: 101-110.
44. Kennedy SM, Ji Z, Rockweiler NB, Hahh AR, Booske JH, et al. (2009) The role of plasmalemmal-cortical anchoring on the stability of transmembrane electropores. IEEE Trans Dielectr Electr Insul 16: 1251-1258.
45. Joshi RP, Schoenbach KH (1999) Electroporation dynamics in biological cells subjected to ultrafast electric pulses: a numerical stimulation study. Phys Rev E 62: 1025-1033.
46. Joshi RP, Hu Q, Aly R, Schoenbach KH (2001) Self-consistent simulations of electroporation dynamics in biological cells subjected to ultrashort electrical pulses. Phys Rev E 64: 011913.
47. Kościuczuk EM, Lisowski P, Jarczak J, Strzalkowska N, Jozwik A et al. (2012) Cathelicidins: family of antimicrobial peptides. Mol Biol Rep 39: 10957-10970.
48. Niu Y, Wu H, Li Y, Hu Y, Padhee S et al. (2013) AA peptides as a new class of antimicrobial agents. Org Biomol Chem 26: 4283-4290.
49. Gabriel B, Teissié J (1997) Direct observation in the millisecond time range of fluorescent molecule asymmetrical interaction with the electropermeabilized cell membrane. Biophys J 73: 2630-2637. (Pubitemid 27471472)
50. Golzio M, Teissié J, Rols MP (2002) Direct visualization at the single-cell level of electrically mediated gene delivery. Proc Natl Acad Sci USA 99: 1292-1297. (Pubitemid 34136486)
51. Li P, Poon YF, Li W, Zhu HY, Yeap SH et al. (2010) A polycationic ant microbial and biocompatible hydrogel with microbe membrane suctioning ability. Nat. Mat. 12: 1-8.
52. Tew GN, Clements D, Tang H, Arnt L, Scott RW (2006) Antimicrobial activity of an abiotic host defense peptide mimic. Biochim Biophys Acta 1758: 1387-1392. (Pubitemid 44436076)
53. Gabriel GJ, Som A, Madkour AE, Eren T, Tew GN (2007) Infectious disease: Connecting innate immunity to biocidal polymers. Mater Sci Eng R 57: 28-64. (Pubitemid 47042367)
54. Bagheri M, Beyermann M, Dathe M (2009) Immobilization reduces the activity of surface-bound cationic antimicrobial peptides with no influence upon the activity spectrum. Antimicrob Agents Chemother 54: 1132-1141.
55. Imazato S, Russell RRB, McCabe JF (1995) Antibacterial activity of MDPB polymer incorporated in dental resin. J Dent 23: 177-181.
56. Sambhy V, Peterson BR, Sen A (2008) Antibacterial and hemolytic activies of pyridinium polymers as a function of the spatial relationship between the positive charge and the pendant alkyl tail. Angew Chem Int Ed 47: 1250-1254.
57. Stratton TR, Rickus JL, Youngblood J (2009) In vitro biocompatibility studies of antibacterial quaternary polymers. Biomacromolecules 10: 2550-2555.
58. Aina OH, Sroka TC, Chen ML, Lam KS (2002) Therapeutic cancer targeting peptides. Biopolymers 66: 184-199. (Pubitemid 35285218)
59. Langer R, Vacanti JP (1993) Tissue engineering. Science 260: 920-926. (Pubitemid 23209960)
60. Gilbert TW, Sellaro TL, Badylak SF (2006) Decellularization of tissues and organs. Biomaterials 27: 3675-3683.
61. Bernard MP, Chu ML, Myers JC, Ramirez F, Eikenberry EF, et al. (1983) Nucleotide sequences of complementary deoxyribonucleic acids for the pro alpha 1 chain of human type I procollagen: Statistical evaluation of structures that are conserved during evolution. Biochemistry 22: 5213-5223.
62. Bernard MP, Myers JC, Chu ML, Ramirez F, Eikenberry EF, et al. (1983) Structure of a cDNA for the pro alpha 2 chain of human type I procollagen: Comparison with chick cDNA for pro alpha 2I identifies structurally conserved features of the protein and the gene. Biochemistry 22: 1139-1145. (Pubitemid 13126372)
63. Constantinou CD, Jimenez SA (1991) Structure of cDNAs encoding the triplehelical domain of murine alpha 2 VI collagen chain and comparison to human and chick homologues: Use of polymerase chain rewaction and partially degenerate oligonucleotide for generation of novel cDNA clones. Matrix 11: 1-9.
64. Exposito JY, D'Alessio M, Solursh M, Ramirez F (1992) Sea urchin collagen evolutionarily homologous to vertebrate pro-alpha 2I collagen. J Biol Chem 267: 15559-15562.
65. Petersen TH, Calle EA, Zhao L, Lee EJ, Gui L, et al. (2010) Tissue-engineered lungs for in vivo implantation. Science 329: 538-541.